Company Filing History:
Years Active: 2004
Title: Gosta Winberg: Innovator in Cell Adhesion Technology
Introduction
Gosta Winberg is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of modified sFv molecules that enhance cell adhesion. His work has implications for improving immune responses against various diseases.
Latest Patents
Gosta Winberg holds a patent for "Modified sFv molecules which mediate adhesion between cells and uses thereof." This innovative patent describes modified sFv molecules that stimulate adhesion between cells, thereby enhancing the immune response against disease. The molecules generally comprise an antigen binding site of an antibody and at least a portion of a transmembrane domain of a cell surface receptor. He has 1 patent to his name.
Career Highlights
Gosta Winberg is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this organization focuses on advancing therapeutic solutions that address critical health challenges.
Collaborations
Throughout his career, Gosta has collaborated with esteemed colleagues, including Jeffrey A. Ledbetter and Martha S. Hayden. These partnerships have contributed to the advancement of research in cell adhesion and immune response.
Conclusion
Gosta Winberg's innovative work in modified sFv molecules represents a significant advancement in biotechnology. His contributions have the potential to enhance immune responses and improve therapeutic outcomes for various diseases.